Nexalis Therapeutics Limited has released a press release.
Quarter 3 Update
Filed with ASX ·
On 6ix: 6ix.com/news/quarter-3-update
6ix hasn’t read this filing yet.
Nexalis Therapeutics Limited on 6ix
Earlier from Nexalis Therapeutics
- Pause in Trading
- CEO appointment
- Reinstatement to Official Quotation
- Private Placement and Market update
- Voluntary Suspension
Later from Nexalis Therapeutics
- $720,500 Private Placement
- Non-renounceable rights issue
- Rights Issue Offer Document
- Placement of Rights Issue Shortfall
- Quarter 4 Update
Follow Nexalis Therapeutics into a list and get an email when it puts out news.
Follow Nexalis Therapeutics